Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wiman

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Biochimica Et Biophysica Acta|October 20, 1970
Characterization of human plasminogen. I. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparationsP Wallén, B Wiman
Biochimica Et Biophysica Acta|July 20, 1990
Complex formation between plasminogen activator inhibitor 1 and vitronectin in purified systems and in plasmaO Sigurdardóttir, B Wiman
Blood|February 1, 1979
Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasmaD Collen, B Wiman
Lakartidningen|January 9, 1991
[New methods accelerate the development of thrombolytic agents]B Wiman, A Hamsten
Seminars in Thrombosis and Hemostasis|July 1, 1990
The fibrinolytic enzyme system and its role in the etiology of thromboembolic diseaseB Wiman, A Hamsten
Biochimica Et Biophysica Acta|January 26, 1972
Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogenP Wallén, B Wiman
Biochimica Et Biophysica Acta|February 23, 1989
Purification of high and low molecular weight plasminogen activator inhibitor 1 from fibrosarcoma cell-line HT 1080 conditioned mediumT Lindahl, B Wiman
European Journal of Biochemistry|October 15, 1975
Amino-acid sequence of the cyanogen-bromide fragment from human plasminogen that forms the linkage between the plasmin chainsB Wiman, P Wallén
Blood|April 1, 1978
Fast-acting plasmin inhibitor in human plasmaD Collen, B Wiman
The American Journal of Cardiology|November 6, 1990
Correlations between fibrinolytic function and acute myocardial infarctionB Wiman, A Hamsten
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Biochimica Et Biophysica Acta|October 20, 1970
Characterization of human plasminogen. I. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparationsP Wallén, B Wiman
Biochimica Et Biophysica Acta|July 20, 1990
Complex formation between plasminogen activator inhibitor 1 and vitronectin in purified systems and in plasmaO Sigurdardóttir, B Wiman
Blood|February 1, 1979
Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasmaD Collen, B Wiman
Lakartidningen|January 9, 1991
[New methods accelerate the development of thrombolytic agents]B Wiman, A Hamsten
Seminars in Thrombosis and Hemostasis|July 1, 1990
The fibrinolytic enzyme system and its role in the etiology of thromboembolic diseaseB Wiman, A Hamsten
Biochimica Et Biophysica Acta|January 26, 1972
Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogenP Wallén, B Wiman
Biochimica Et Biophysica Acta|February 23, 1989
Purification of high and low molecular weight plasminogen activator inhibitor 1 from fibrosarcoma cell-line HT 1080 conditioned mediumT Lindahl, B Wiman
European Journal of Biochemistry|October 15, 1975
Amino-acid sequence of the cyanogen-bromide fragment from human plasminogen that forms the linkage between the plasmin chainsB Wiman, P Wallén
Blood|April 1, 1978
Fast-acting plasmin inhibitor in human plasmaD Collen, B Wiman
The American Journal of Cardiology|November 6, 1990
Correlations between fibrinolytic function and acute myocardial infarctionB Wiman, A Hamsten
Pageof 13